ReviewCancers2026

Neoadjuvant Systemic Therapy for Resectable Intrahepatic Cholangiocarcinoma: From Retrospective Studies to Randomized Evidence.

Hironobu Suto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.